Clinical Trials on Rectal Cancer

Total 126310 results

Azienda Ospedaliero, Universitaria Pisana

Completed

Folfoxiri Plus Bevacizumab Followed by Chemoradiotherapy Plus Bevacizumab in Patients With Resectable Rectal Cancer (TRUST)

Rectal Cancer

Italy
Region Skane

Completed

Action of Synbiotics on Irradiated GI Mucosa in Rectal Cancer Treatment (FIPIREX)

Rectal Cancer
Beijing Friendship Hospital
The First Affiliated Hospital of Nanchang University; LanZhou University; Peking... and other collaborators

Unknown

Chinese TaTME Registry Collaborative

Rectal Cancer

China
Second Hospital of Jilin University

Unknown

Intersphincteric Resection With or Without Intraoperative Radiation in Rectal Cancer (IDAVON)

Rectal Cancer

China
Chinese PLA General Hospital

Unknown

A Pilot Study of Neoadjuvant Chemotherapy Combined With Bevacizumab for Locally Advanced Rectal Cancer

Rectal Cancer

China
Trans Tasman Radiation Oncology Group

Completed

Preoperative Radiotherapy and Chemotherapy in Patients With Locally Advanced Rectal Cancer (PROArCT)

Rectal Cancer

Australia
Second Hospital of Jilin University

Unknown

Study of Intraoperative Radiotherapy for Middle and Low Rectal Cancer (IROT)

Rectal Cancer

China
Memorial Sloan Kettering Cancer Center

Completed

Advanced MR Imaging for Early Biologic Tumor Changes to Neoadjuvant Chemoradiation Treatment for Rectal Cancer

Rectal Cancer

United States
Seoul National University Hospital
HK inno.N Corporation

Unknown

The Effect Of Probiotics On Bowel Function Restoration After Ileostomy Closure In Patients With Rectal Cancer

Rectal Cancer
Hoffmann-La Roche
Sanofi-Synthélabo (Schweiz) AG

Completed

A Study of Capecitabine Plus Oxaliplatin in Combination With Pre-operative Pelvic Radiotherapy in Rectal Cancer

Rectal Cancer

Switzerland
National Taiwan University Hospital

Completed

Preoperative Chemoradiotherapy Utilizing Intensity Modulated Radiation Therapy in Combination With Bevacizumab-FOLFOX

Rectal Cancer

Taiwan
US Oncology Research
Bristol-Myers Squibb; Eli Lilly and Company

Completed

Pre-op Rectal ChemoRad +/- Cetuximab

Rectal Cancer

United States
Spanish Cooperative Group for the Treatment of...
Hoffmann-La Roche

Completed

Safety and Efficacy Study to Compare Capecitabine + Bevacizumab Versus Capecitabine, Concomitantly With Radiotherapy as Neoadjuvant Treatment for Patients With Localized and Resectable Rectal Cancer (AVAXEL)

Rectal Cancer

Spain
Oslo University Hospital

Completed

Oxaliplatin and 5-FU Based Preoperative Chemoradiation (LARC-RRP)

Rectal Cancer

Norway
H. Lee Moffitt Cancer Center and Research Institute
Bayer

Completed

Pre-operative 5-Fluorouracil (5-FU) and Sorafenib With External Radiation in Locally Advanced Rectal Cancer

Rectal Cancer

United States
LifeBond Ltd.

Completed

LifeSeal™ Pilot Study in Subjects Undergoing Circular Stapled Anastomosis Created Within 10 cm of the Anal Verge

Rectal Cancer

Israel, Belgium, Sweden
University of Virginia
American Cancer Society, Inc.

Withdrawn

Feasibility Study to Develop Sentinel Lymph Node Mapping in Rectal Cancer Patients

Rectal Cancer

United States
Mansoura University

Unknown

Minimally Invasive Sphincter Sparing Total Mesorectal Excision for Ultra-low Rectal Cancer After Initial Chemo-radiotherapy (MISS-TRICR). (MISS-TRICR)

Rectal Cancer

Egypt
Maria Sklodowska-Curie National Research Institute...

Unknown

Preoperative Hyperfractionated Radiotherapy or Radiochemotherapy in Locally Advanced Rectal Cancer.

Rectal Cancer

Poland
Kyungpook National University Hospital

Completed

The Efficacy of Penile Rehabilitation Using Udenafil After Total Mesorectal Excision of Rectal Cancer

Rectal Cancer

Korea, Republic of
University of Arkansas

Withdrawn

Hydralazine as a Demethylating Agent in Rectal Cancer

Rectal Cancer
Cancer Institute and Hospital, Chinese Academy...

Unknown

Trial of Using SIB-IMRT in Preoperative Radiotherapy for Locally Advanced Rectum Cancer

Rectal Cancer

China
Yonsei University

Completed

A Study of Neoadjuvant Chemoradiotherapy With 5-FU/Leucovorin (FL) vs. TS-1/Irinotecan in Patients With Locally Advanced Rectal Cancer

Rectal Cancer

Korea, Republic of
Beth Israel Medical Center
St. Luke's-Roosevelt Hospital Center

Withdrawn

Phase II Trial of Preoperative High-dose-rate Endorectal Brachytherapy and FOLFOX Chemotherapy for Rectal Cancer (HDRBT)

Rectal Cancer

United States
Clinical Research Support Center Kyush

Unknown

RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301).

Rectal Cancer

Japan
Odense University Hospital

Unknown

Comparing of Different Biomarkers From Vena Rectalis Superior and Vena Cubiti in Patients Undergoing Low Anterior Resection for Rectum Cancer

Rectal Cancer

Denmark
Beijing Chao Yang Hospital

Unknown

Conventional Versus Individual Extralvator Abdominoperineal Excision for Advanced Lower Rectal Cancer (ELAPE)

Rectal Cancer

China
Wakayama Medical University

Completed

Comparison of Low and High Ligation in the Rectal Cancer

Rectal Cancer

Japan
LifeBond Ltd.

Completed

LifeSeal™ Preliminary Study in Subjects Undergoing Low Anterior Resection

Rectal Cancer

Sweden
University of Lausanne Hospitals

Unknown

Diagnostic Value of Whole-Body MRI for Rectal Cancer Preoperative Staging

Rectal Cancer

Switzerland
Ottawa Hospital Research Institute
Sanofi; Hoffmann-La Roche; Ottawa Regional Cancer Foundation

Unknown

IXO (Irinotecan, Xeloda, Oxaliplatin) in Rectal Cancer (IXOr)

Rectal Cancer

Canada
Memorial Sloan Kettering Cancer Center

Completed

Evaluating The Response to Pre-Operative Chemotherapy and/or Radiation Therapy For Rectal Cancer Using Three-Dimension Transrectal Ultrasound

Rectal Cancer

United States
M.D. Anderson Cancer Center
Genentech, Inc.

Completed

Neoadjuvant Chemoradiation With RHUMAB VEGF (Avastin) for Rectal Cancer

Rectal Cancer

United States
National Cancer Center, Korea

Completed

Short-course Preoperative Chemoradiotherapy Followed by Delayed Operation for Locally Advanced Rectal Cancer

Rectal Cancer

Korea, Republic of
Fudan University
Zhejiang Cancer Hospital; RenJi Hospital; First People Hospital of Zhejiang

Unknown

A Trial of High Intensity Versus Low Intensity Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

Rectal Cancer

China
Peter MacCallum Cancer Centre, Australia

Completed

A Single Arm Trial of Oxaliplatin and 5FU With Concurrent Radiation in Patients With Metastatic Rectal Cancer

Rectal Cancer

Australia
Institute of Oncology Ljubljana

Unknown

Induction Chemotherapy,Radiochemotherapy, Consolidation Chemotherapy in Preoperative Treatment of Rectal Cancer

Rectal Cancer

Slovenia
Fudan University

Unknown

Genotype-driven Phase I Study of Irinotecan Administered in Neoadjuvant Chemoradiotherapy in Patients With Stage II/III Rectal Cancer

Rectal Cancer

China
Asan Medical Center

Completed

Comparison of Preoperative and Postoperative Radiotherapy and Capecitabine in Locally Advanced Rectal Cancer

Rectal Cancer

Korea, Republic of
University of Sao Paulo

Unknown

Use of Positron Emission Tomography/Computed Tomography (PET/CT) to Assess Tumor Response to Neoadjuvant Treatment for Distal Rectal Cancer

Rectal Cancer

Brazil
Tata Memorial Hospital

Unknown

Concurrent Chemo-Radiotherapy Versus Radiotherapy With Boost in Locally Advanced Unresectable Rectal Cancers

Rectal Cancer

India
Rectal Cancer Trial on Defunctioning Stoma Study...

Unknown

Early Reversal of Defunctioning Stoma Trial (ELSOR)

Rectal Cancer

Sweden
Hamilton Health Sciences Corporation
Canadian Institutes of Health Research (CIHR)

Unknown

Quality Initiative in Rectal Cancer (QIRC) Trial

Rectal Cancer
Qu Shen
The First Affiliated Hospital of Xiamen University

Not yet recruiting

Multidimensional Rehabilitation Intervention in Colorectal Cancer Survivors - a Pilot Study

Quality of Life | Rehabilitation | Pilot Study | Colorectal Cancer Survivor
German Breast Group
Roche Pharma AG; Celgene Corporation

Completed

Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto) (GeparSepto)

Inflammatory Breast Cancer | HER-2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage III | Inflammatory Breast Cancer Stage IV

Germany
German Breast Group
GlaxoSmithKline; Roche Pharma AG; Teva Pharmaceuticals USA

Completed

Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer (GeparSixto)

Inflammatory Breast Cancer | HER-2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage III | Inflammatory Breast Cancer Stage IV

Germany
The First Affiliated Hospital with Nanjing Medical...

Not yet recruiting

Evaluation of the Efficacy and Safety of Interleucin-2 Combined With PD-1 Monoclonal Antibody and CAPOX in Preoperative Neoadjuvant Therapy for Locally Advanced Rectal Cancer - a Multicenter, Single-arm, Open-label Clinical Trail

Locally Advanced Rectal Adenocarcinoma
Vejle Hospital

Recruiting

MRI T1 Relaxation Time in Rectal Cancer

Rectal Cancer | Locally Advanced Rectal Carcinoma

Denmark
University Hospital, Bordeaux

Recruiting

Endorectal Brachytherapy for Rectal Cancer (ICUREC)

Locally Advanced Rectal Carcinoma

France
Aalborg University Hospital

Recruiting

Radiation-induced Diarrhoea During Curative EBRT of Prostate and Rectal Cancer (PRECANU)

Radiation-induced Diarrhoea in Prostate and Rectal Cancer

Denmark

3

Subscribe